Skip to main content

Peer Review reports

From: Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis

Original Submission
5 Nov 2017 Submitted Original manuscript
27 Nov 2017 Author responded Author comments - yan wang
Resubmission - Version 2
27 Nov 2017 Submitted Manuscript version 2
15 Mar 2018 Reviewed Reviewer Report - Toshikazu Moriwaki
24 Mar 2018 Reviewed Reviewer Report - Daniel Reim
16 Apr 2018 Author responded Author comments - yan wang
Resubmission - Version 3
16 Apr 2018 Submitted Manuscript version 3
18 Apr 2018 Reviewed Reviewer Report - Toshikazu Moriwaki
30 Apr 2018 Reviewed Reviewer Report - Daniel Reim
15 May 2018 Author responded Author comments - yan wang
Resubmission - Version 4
15 May 2018 Submitted Manuscript version 4
28 May 2018 Author responded Author comments - yan wang
Resubmission - Version 5
28 May 2018 Submitted Manuscript version 5
16 Jun 2018 Author responded Author comments - yan wang
Resubmission - Version 6
16 Jun 2018 Submitted Manuscript version 6
Publishing
20 Jun 2018 Editorially accepted
28 Jun 2018 Article published 10.1186/s12885-018-4615-z

You can find further information about peer review here.

Back to article page